Bellerophon Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLPH and other ETFs, options, and stocks.

About BLPH

Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. 

CEO
Peter Fernandes
CEOPeter Fernandes
Employees
20
Employees20
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
2009
Founded2009
Employees
20
Employees20

BLPH Key Statistics

Market cap
9.70M
Market cap9.70M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
6.15K
Average volume6.15K
High today
High today
Low today
Low today
Open price
$0.99
Open price$0.99
Volume
0.00
Volume0.00
52 Week high
$3.72
52 Week high$3.72
52 Week low
$0.67
52 Week low$0.67

BLPH Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 30, After Hours
ActualExpected Mar 30, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.